<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>熊说肿瘤｜MSKCC 尚待解决的肿瘤基因组检测临床应用问题 - 文字轨迹</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/others/%E7%86%8A%E8%AF%B4%E8%82%BF%E7%98%A4_mskcc_%E5%B0%9A%E5%BE%85%E8%A7%A3%E5%86%B3%E7%9A%84%E8%82%BF%E7%98%A4%E5%9F%BA%E5%9B%A0%E7%BB%84%E6%A3%80%E6%B5%8B%E4%B8%B4%E5%BA%8A%E5%BA%94%E7%94%A8%E9%97%AE%E9%A2%98/"><meta property="og:site_name" content="文字轨迹"><meta property="og:title" content="熊说肿瘤｜MSKCC 尚待解决的肿瘤基因组检测临床应用问题"><meta property="og:description" content="熊说肿瘤｜MSKCC 尚待解决的肿瘤基因组检测临床应用问题 by 熊言熊语 写在前面"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2023-02-04T13:45:44+00:00"><meta property="article:modified_time" content="2023-02-04T13:45:44+00:00"><meta property="article:tag" content="Fetched"><meta property="article:tag" content="熊言熊语"><meta itemprop=name content="熊说肿瘤｜MSKCC 尚待解决的肿瘤基因组检测临床应用问题"><meta itemprop=description content="熊说肿瘤｜MSKCC 尚待解决的肿瘤基因组检测临床应用问题 by 熊言熊语 写在前面"><meta itemprop=datePublished content="2023-02-04T13:45:44+00:00"><meta itemprop=dateModified content="2023-02-04T13:45:44+00:00"><meta itemprop=wordCount content="102"><meta itemprop=keywords content="Fetched,熊言熊语"><meta name=twitter:card content="summary"><meta name=twitter:title content="熊说肿瘤｜MSKCC 尚待解决的肿瘤基因组检测临床应用问题"><meta name=twitter:description content="熊说肿瘤｜MSKCC 尚待解决的肿瘤基因组检测临床应用问题 by 熊言熊语 写在前面"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=文字轨迹 rel=home><div class="logo__item logo__text"><div class=logo__title>文字轨迹</div><div class=logo__tagline>故事流淌过的地方</div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>文章</span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>标签</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>关于</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>熊说肿瘤｜MSKCC 尚待解决的肿瘤基因组检测临床应用问题</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2023-02-04T13:45:44Z>2023-02-04</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/duty/ rel=category>Duty</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#熊说肿瘤mskcc-尚待解决的肿瘤基因组检测临床应用问题-by-熊言熊语>熊说肿瘤｜MSKCC 尚待解决的肿瘤基因组检测临床应用问题 by 熊言熊语</a></li></ul></nav></div></div><div class="content post__content clearfix"><h2 id=熊说肿瘤mskcc-尚待解决的肿瘤基因组检测临床应用问题-by-熊言熊语>熊说肿瘤｜MSKCC 尚待解决的肿瘤基因组检测临床应用问题 by 熊言熊语</h2><div><p><strong><span>写在前面</span></strong><br></p><section><span>MSK前瞻性临床队列 MSK-IMPACT和MSK-ACCESS样本量突破10万之后，MSKCC的分子肿瘤中心 (Center for Molecular Oncology, CMO) 主任 David Solit 最近在个人社交媒体上晒了这样一个截图，并补充到：</span></section><blockquote><section>随着数十种tumor-agnostic和肿瘤特异性的基因组生物标记得到FDA批准，肿瘤以及胚系基因组检测应该被考虑用于<strong>所有需要系统治疗</strong>的癌症患者。</section></blockquote><p><img data-galleryid data-ratio=0.4258289703315881 data-s=300,640 data-src="https://mmbiz.qpic.cn/mmbiz_png/vMCuh4qxbFkSDTrFVoMD4eh0ibxR78cUpsCicUgqIxkiahztOuGCJa8TDg67uHCneAmficAdyqOpju8zkMNVWRQMxQ/640?wx_fmt=png" data-type=png data-w=1146 src="https://mmbiz.qpic.cn/mmbiz_png/vMCuh4qxbFkSDTrFVoMD4eh0ibxR78cUpsCicUgqIxkiahztOuGCJa8TDg67uHCneAmficAdyqOpju8zkMNVWRQMxQ/640?wx_fmt=png"></p><blockquote><section><span></span></section></blockquote><figure data-type=image tabindex=1><img data-ratio=0.5231481481481481 data-src="https://mmbiz.qpic.cn/mmbiz_jpg/vMCuh4qxbFkSDTrFVoMD4eh0ibxR78cUpKhCFB12AKzDib02mfoOoRMTgtpvgH0NSt9iccwxsg1uTJMr2saGyHiamg/640?wx_fmt=jpeg" data-type=jpeg data-w=1080 src="https://mmbiz.qpic.cn/mmbiz_jpg/vMCuh4qxbFkSDTrFVoMD4eh0ibxR78cUpKhCFB12AKzDib02mfoOoRMTgtpvgH0NSt9iccwxsg1uTJMr2saGyHiamg/640?wx_fmt=jpeg"></figure><hr><h2></h2><h2><span><strong>关于MSK-IMPACT和MSK-ACCESS</strong></span><span></span><br></h2><section><span>MSK-IMPACT中IMPACT是Integrated Mutation Profiling of Actionable Cancer Targets的缩写。</span></section><section><span>IMPACT panel 可以检测的基因数量也经历了很多版不同的变化，从最早的341基因到410 基因到2017年FDA获批时的468基因，再到如今的505基因，可以同时进行MSI和TMB检测。</span></section><section><span>而MSK-ACCESS中的ACCESS是指 Analysis of Circulating cfDNA to Evaluate Somatic Status，它从IMPACT中挑选了129个关键的肿瘤相关基因，在cfDNA中进行深度测序。</span></section><hr><section><span></span></section><h2><strong>尚未完全回答的临床应用问题</strong><br></h2><section><span>更值得关注的是，在「展示成果」的同时，<span>David Solit </span>还提出了自己想到的，<strong>8个关于肿瘤NGS检测临床应用尚未完全解决的问题</strong>。</span></section><section><span>如果你目前就在这个领域中，也许其中有些 point 会给你启发。</span></section><section><span>1. <strong>cfDNA能否取代肿瘤组织进行检测</strong>，如果可以的话是针对哪些病人，什么时候cfDNA和肿瘤组织检测又是互补的呢？</span></section><section><span>2. 更全面的<strong>全外显子组/全基因组测序</strong>在临床中的应用是什么？</span></section><section><span>3. 与其配套其它技术平台，比如<strong>全转录组测序和蛋白质组学</strong>的的应用又是什么？</span></section><section><span>4. <strong>哪些人应该进行胚系检测</strong>？胚系突变不仅可以为遗传性癌症风险提供信息，而且还可以成为药物反应的生物标志物。</span></section><section><span>5. <strong>怎样才能提高肿瘤/胚系检测的可及性</strong>？如果需要进行基因组分析来确定最有效的治疗方法，无法获得这种技术的患者很可能就不能得到最好的治疗。</span></section><section><span>6.<strong>如何才能扩大精准肿瘤治疗的影响</strong>？最重要的是需要更好的药物，仍然有太多「无法治疗」的靶点，比如RB1、TP53、STK11、NF1和多数RAS突变。我们也需要更多具有选择性/低毒性的药物以便进行更精准的联合治疗。</span></section><section><span>7. 我们还<strong>需要更低的检测价格</strong>（这是采用全基因组测序的主要障碍）以及更好的报告注释。</span><span></span></section><section><span>8. 还能从目前的panel测序中得出哪些更丰富的信息：</span><strong><span>大片段拷贝数；</span><span>杂合性缺失评估；</span><span>靶向突变克隆性评估；</span><span>更好的signatures分析来为突变解读提供信息</span></strong><span>。</span><span></span></section><hr><h2><span><strong><br>从5万到10万样本的变与不变</strong></span></h2><section><span>MSK-IMPACT 和 MSK-ACCESS 样本突破10万例的时间是<strong>2023年2月</strong>，而<strong>2020年1月</strong>这个数字刚来到5万。</span></section><section><span>下图是当时他晒出来的样本量截图。</span></section><figure data-type=image tabindex=2><img data-ratio=0.5359801488833746 data-src="https://mmbiz.qpic.cn/mmbiz_png/vMCuh4qxbFkSDTrFVoMD4eh0ibxR78cUp0fW4ib0iaUJecH2rMSd6VBeWD88VtRzoiazGroAsibicDQgibmop5Woaw0Mw/640?wx_fmt=png" data-type=png data-w=806 src="https://mmbiz.qpic.cn/mmbiz_png/vMCuh4qxbFkSDTrFVoMD4eh0ibxR78cUp0fW4ib0iaUJecH2rMSd6VBeWD88VtRzoiazGroAsibicDQgibmop5Woaw0Mw/640?wx_fmt=png"></figure><section><span>好巧不巧，该说不说。</span></section><section><span>3年前样本量突破五万的时候，David Solit 同样发表了一些他自己的想法和评论（</span><span>可以看作未解之谜前传</span><span>）。</span></section><p><img data-galleryid data-ratio=0.4204152249134948 data-s=300,640 data-src="https://mmbiz.qpic.cn/mmbiz_png/vMCuh4qxbFkSDTrFVoMD4eh0ibxR78cUpjz2d7icyz9iaS2a4D6yAMdgzlbZiaBnYZZa8FFuiambLckB0aiaY6rprG8w/640?wx_fmt=png" data-type=png data-w=1156 src="https://mmbiz.qpic.cn/mmbiz_png/vMCuh4qxbFkSDTrFVoMD4eh0ibxR78cUpjz2d7icyz9iaS2a4D6yAMdgzlbZiaBnYZZa8FFuiambLckB0aiaY6rprG8w/640?wx_fmt=png"></p><section><span>我顺手整理出来，可以看看这三年</span><span>他的想法哪些变了哪些没变，是否又有什么问题得到了回答。</span></section><section><span></span><span></span></section><section><strong><span>以下10条是三年前他的观点和想法。</span></strong><span></span></section><section><span>1. 所有<strong>晚期癌症患者</strong>都应考虑进行肿瘤NGS检测。肿瘤NGS历来被认为只是一个辅助诊</span><span>断手段，主要是那些系统性进行靶向治疗的患者需要，这样的想法低估了其临床价值。</span></section><section><span>2. 肿瘤NGS检测对以下几项内容也很关键：确保正确的癌症类型诊断，这将影响手术、放疗和化疗的决策；了解患者复发和死亡风险；评估可遗传的胚系突变。</span></section><p><span>3. 一些专家认为肿瘤NGS和精准治疗约等于「夸大其词」。在MSK的经验中大约40%的晚期癌症患者治疗直接取决于肿瘤NGS检测结果。为什么这个比例似乎不高呢？</span></p><section><span>到目前为止，MSK队列中发现的最常见突变清楚地说明了更多患者并未从靶向治疗中受益的主要原因。</span><span>如下图所示，我们对大多数基因突变(TP53、TERT、APC、NF1)驱动缺乏有效的靶向治疗。</span><br></section><figure data-type=image tabindex=3><img data-ratio=0.2851851851851852 data-src="https://mmbiz.qpic.cn/mmbiz_jpg/vMCuh4qxbFkSDTrFVoMD4eh0ibxR78cUpYfrE7CbS6L8S4318d7J4LgiceFHDGpOmiaXpKHyQ8JBjcRAiaoicAQ9xWA/640?wx_fmt=jpeg" data-type=jpeg data-w=1080 src="https://mmbiz.qpic.cn/mmbiz_jpg/vMCuh4qxbFkSDTrFVoMD4eh0ibxR78cUpYfrE7CbS6L8S4318d7J4LgiceFHDGpOmiaXpKHyQ8JBjcRAiaoicAQ9xWA/640?wx_fmt=jpeg"></figure><section><span>可见，<strong>增加受益于肿瘤NGS检测的患者比例需要更多的新药开发</strong>。</span></section><section><span>4. 根据MSK的经验，更大范围的NGS检测可以一定程度上扩大指导范围。</span><span>那测多少才够呢？</span><span><br></span></section><section><span>肿瘤NGS检测通常有3个结果：</span><span>确定可信</span><span>的可靶向驱动因素；</span><span>确定可信的足以让细胞发生</span><span>转化</span><span>的非靶向驱动</span><span>因素；</span><span>没</span><span>有找到可靶向</span><span>的驱动因素。</span><span>根据</span><span>经验，</span><strong><span>更</span><span>大范围的NGS</span><span>检测主要是可能让第三组患者增加收益</span></strong><span>。</span><span></span></section><section><span>在少数情况下，识别被靶向测序遗漏的<strong>基因融合</strong>可能会影响治疗结果。将来在可靶向驱动因素的患者中<strong>识别伴发突变</strong>也可能促使靶向治疗的合理组合。</span></section><section><span>5. 更大范围的NGS检测目前看来可以识别预测药物敏感性的突变特征（比如 MSI），不过能够识别HRD或其他特征的WGS检测是否真的有临床价值仍有待确认。</span></section><section><span>6. 我们是否仍需要争论<strong>配对肿瘤和正常组织测序是否是最佳方法</strong>？越来越清楚的是最好对「正常」样本同时进行分析以确保突变不是来自胚系或克隆造血。</span></section><section><span>7. <strong>cfDNA 在哪里应用更合适呢</strong>？cfDNA显然比肿瘤组织NGS检测有一些好处。比如：</span><span>更容易获得样本和更短的周转时间；</span><span>更容易对患者进行重复采样；</span><span>更好地反映肿瘤异质性。</span></section><section><span>然而，cfDNA 检测必须进行更深的测序，这意味着更高的测序成本和通常更少的检测基因数量。</span></section><section><strong><span>由于肿瘤DNA脱落率低，就有可能出现假阴结果；</span><span>而敏感性又因突变类型而不同，</span><span>克隆性造血也可能会混淆结果。</span></strong><span></span></section><section><span></span></section><section><span>因此，肿瘤和血液NGS检测可能会被证明是互补而非竞争的方法。</span><strong><span>医生</span><span>需要能正确地</span><span>识别</span><span>可能因肿瘤来源</span><span>DN</span><span>A比</span><span>例低</span><span>而错过关键突变的患者</span></strong><span>。</span></section><section><span>8. MSKCC 接下来该怎么做？</span><span>关键步骤是不断收集参与MSKCC前瞻性计划的数万名患者的临床治疗信息和检测结果数据。</span><span> </span></section><section><span>我们需要更好地了解</span><span>为什么病人从目前的治疗中获得了不同的益处。</span><span>加快开发更有效的方法</span><span>治疗那些现有方法无法获益的患者，</span><span>为那些能够获益的患者找到毒性更小的方案。</span></section><section><span>9. 为了促进这项工作，MSKCC 同样是 <strong>AACR GENIE 项目</strong>的创始成员之一，这一计划将汇集世界各地机构的基因组和临床数据，更好地了解特定基因组图谱如何影响癌症患者预后。</span></section><section><span>10. 期待未来几年MSKCC的团队合作能够充分揭示基于肿瘤和血液NGS检测的应用潜力。</span></section><section><span>好了，以上就是本次推送的全部内容，我们下次再见👋<br></span></section><hr><section><span></span></section><section data-snip-inherited=58><strong data-snip-rule=118 data-snip-inherited=58><span>有什么想聊的想问的 </span><span>留言区见</span></strong></section><section data-snip-inherited=58><span data-snip-inherited=58>你可能还想读</span></section><ul data-snip-rule=69 data-snip-inherited=58><li><p><a target=_blank href="http://mp.weixin.qq.com/s?__biz=MzA5OTM1ODg5NA==&amp;mid=2649680447&amp;idx=1&amp;sn=bd584c0caeab3e26070aae9ca530b93b&amp;chksm=8899cbfebfee42e83ec0591cb294b681aab6329e7fb0685c35290ceb359f621ee5cc5a34bec2&amp;scene=21#wechat_redirect" textvalue="一则新闻引发的好奇：那些获得 FDA 突破性设备认证的多癌种早筛前辈" linktype=text imgurl imgdata=null data-itemshowtype=0 tab=innerlink data-linktype=2>一则新闻引发的好奇：那些获得 FDA 突破性设备认证的多癌种早筛前辈</a><br></p></li><li><section><a target=_blank href="http://mp.weixin.qq.com/s?__biz=MzA5OTM1ODg5NA==&amp;mid=2649680343&amp;idx=1&amp;sn=e1c72ec4626407da82bf32a0afa1fa51&amp;chksm=8899c816bfee4100afbecf7821d6c834f019916c889807968742c8b1bbbe403952f2ba8d096a&amp;scene=21#wechat_redirect" textvalue=肿瘤NGS行业新人如何构建知识体系 linktype=text imgurl imgdata=null data-itemshowtype=0 tab=innerlink data-linktype=2 hasload=1>肿瘤NGS行业新人如何构建知识体系</a></section></li><li><section><a target=_blank href="http://mp.weixin.qq.com/s?__biz=MzA5OTM1ODg5NA==&amp;mid=2649680426&amp;idx=1&amp;sn=65338989555f46828eec0129b2d43e58&amp;chksm=8899cbebbfee42fdadbbebcf20e9d279bdad3937cc9759625f4bf10e62095471f3d6a7b7736b&amp;scene=21#wechat_redirect" textvalue="和头部肿瘤早筛公司 GRAIL CEO 学写年终工作总结" linktype=text imgurl imgdata=null data-itemshowtype=0 tab=innerlink data-linktype=2 hasload=1>和头部肿瘤早筛公司 GRAIL CEO 学写年终工作总结</a></section></li><li><section><a target=_blank href="http://mp.weixin.qq.com/s?__biz=MzA5OTM1ODg5NA==&amp;mid=2649680362&amp;idx=1&amp;sn=c8dc8bc3e583cd0b8afbf4ac4ad29543&amp;chksm=8899c82bbfee413d6fd5efff8a1237dd46e5841b8168cb7aca3567e4407ccbb60fccbd981146&amp;scene=21#wechat_redirect" textvalue="npj Precision Oncology｜Foundation Medicine 发表超大人群KRAS突变泛癌研究" linktype=text imgurl imgdata=null data-itemshowtype=0 tab=innerlink data-linktype=2 hasload=1>npj Precision Oncology｜Foundation Medicine 发表超大人群KRAS突变泛癌研究</a></section></li><li><section><a target=_blank href="http://mp.weixin.qq.com/s?__biz=MzA5OTM1ODg5NA==&amp;mid=2649680399&amp;idx=1&amp;sn=4784bac09dbee8a7d94abea08f438888&amp;chksm=8899cbcebfee42d80a5eb9c77338c5049a0b3e36242a127a68c57b2eb859866a36f765842f9d&amp;scene=21#wechat_redirect" textvalue=熊说肿瘤｜从2002年的Nature论文到2022年的亿元营收，文献之外的故事 linktype=text imgurl imgdata=null data-itemshowtype=0 tab=innerlink data-linktype=2 hasload=1>熊说肿瘤｜从2002年的Nature论文到2022年的亿元营收，文献之外的故事</a><br></section></li><li><section><a target=_blank href="http://mp.weixin.qq.com/s?__biz=MzA5OTM1ODg5NA==&amp;mid=2649680291&amp;idx=1&amp;sn=61e93d155e7b7ca295f57db6ee359087&amp;chksm=8899c862bfee4174f1ce75ebb6e2434cb67af456e966c97adddde150536339bc1a46fd52f1d9&amp;scene=21#wechat_redirect" textvalue="熊说肿瘤｜Nature Reviews Cancer 发文：未来10年肿瘤精准治疗的6个未解之谜" linktype=text imgurl imgdata=null data-itemshowtype=0 tab=innerlink data-linktype=2 hasload=1>熊说肿瘤｜Nature Reviews Cancer 发文：未来10年肿瘤精准治疗的6个未解之谜</a><br></section></li><li><section><a target=_blank href="http://mp.weixin.qq.com/s?__biz=MzA5OTM1ODg5NA==&amp;mid=2649680237&amp;idx=1&amp;sn=b9643d438e2e178e896b4e53d8d8a79f&amp;chksm=8899c8acbfee41ba9b24a5f264bf59a802dc30e1bec0c93f8aff75b0de572fdda3af04178581&amp;scene=21#wechat_redirect" textvalue=熊说肿瘤｜跨越70年的癌症靶向治疗里程碑 linktype=text imgurl imgdata=null data-itemshowtype=0 tab=innerlink data-linktype=2 data-snip-rule=121 hasload=1>熊说肿瘤｜跨越70年的癌症靶向治疗里程碑</a><br></section></li><li><section><a target=_blank href="http://mp.weixin.qq.com/s?__biz=MzA5OTM1ODg5NA==&amp;mid=2649680170&amp;idx=1&amp;sn=25e30b5e07c8f2f49d36443b811870a8&amp;chksm=8899c8ebbfee41fd4d9c625e58bd127f6a824123dc8017b75317acd4850b6b4efaf5814fc4f4&amp;scene=21#wechat_redirect" textvalue=熊说肿瘤｜同样做肿瘤NGS检测，美股上市的这9家公司近况如何 linktype=text imgurl imgdata=null data-itemshowtype=0 tab=innerlink data-linktype=2 data-snip-rule=127 hasload=1>熊说肿瘤｜同样做肿瘤NGS检测，美股上市的这9家公司近况如何</a></section></li><li><section><a target=_blank href="http://mp.weixin.qq.com/s?__biz=MzA5OTM1ODg5NA==&amp;mid=2649680049&amp;idx=1&amp;sn=09511b12032c9c1b79821de42ae2e755&amp;chksm=8899c970bfee4066f18f69724f0b01ab34702932be28b8d96fcc629355c885e9f23d6139e8fe&amp;scene=21#wechat_redirect" textvalue=熊读文献｜染色体不稳定性，凭什么2022年还能用TCGA数据发Nature？ linktype=text imgurl imgdata=null data-itemshowtype=0 tab=innerlink data-linktype=2 hasload=1 data-snip-rule=129>熊读文献｜染色体不稳定性，凭什么2022年还能用TCGA数据发Nature？</a><br></section></li><li><section><a target=_blank href="http://mp.weixin.qq.com/s?__biz=MzA5OTM1ODg5NA==&amp;mid=2649679887&amp;idx=1&amp;sn=153ccd8f383075aa7b11f47de4b90751&amp;chksm=8899c9cebfee40d8c1b2f7eb47c260a61674ba5c245d7f9832809c37a65d6080aba40cdd203c&amp;scene=21#wechat_redirect" textvalue=熊推荐书｜在《Google软件工程》里了解如何在团队内进行学习和分享 linktype=text imgurl imgdata=null data-itemshowtype=0 tab=innerlink data-linktype=2 hasload=1 data-snip-rule=130>熊推荐书｜在《Google软件工程》里了解如何在团队内进行学习和分享</a></section></li><li><section><span data-snip-rule=122><a target=_blank href="http://mp.weixin.qq.com/s?__biz=MzA5OTM1ODg5NA==&amp;mid=2649679882&amp;idx=1&amp;sn=d90adf7720a27e7c2ba3dee0c4969cc4&amp;chksm=8899c9cbbfee40dde54afc80aaf9bf52b16991f89c1094cc2eb22e01c87f2294b92d6c8cf246&amp;scene=21#wechat_redirect" textvalue=熊说肿瘤｜FDA发布ctDNA应用于早期实体瘤药物开发的指导意见 linktype=text imgurl imgdata=null data-itemshowtype=0 tab=innerlink data-linktype=2 hasload=1 data-snip-rule=134>熊说肿瘤｜FDA发布ctDNA应用于早期实体瘤药物开发的指导意见</a></span></section></li><li><section><a target=_blank href="http://mp.weixin.qq.com/s?__biz=MzA5OTM1ODg5NA==&amp;mid=2649679704&amp;idx=1&amp;sn=b48d138b1a68e9fb642dc9f3a6a263f4&amp;chksm=8899c699bfee4f8f5941bd65c47a2ad707c03e95aef7ce01d7ea77047e6722301440d81f814f&amp;scene=21#wechat_redirect" textvalue=在陌生领域开始读文献，我劝你别读正文 linktype=text imgurl imgdata=null data-itemshowtype=0 tab=innerlink data-linktype=2 wah-hotarea=click data-snip-rule=261 hasload=1>在陌生领域开始读文献，我劝你别读正文</a><br></section></li><li><section><a target=_blank href="http://mp.weixin.qq.com/s?__biz=MzA5OTM1ODg5NA==&amp;mid=2649679742&amp;idx=1&amp;sn=c7b66d547e79947e8b37e0272bb50a1d&amp;chksm=8899c6bfbfee4fa9786812420d899005acfaaddd6ad3823c77e7f6d59e62a834fc59f06c0cbd&amp;scene=21#wechat_redirect" textvalue=你也可以在学术报告中讲好一个引人入胜的故事 linktype=text imgurl imgdata=null data-itemshowtype=0 tab=innerlink data-linktype=2 hasload=1 data-snip-rule=132>你也可以在学术报告中讲好一个引人入胜的故事</a></section></li></ul><section data-snip-inherited=58><span data-snip-inherited=58><br></span></section><section data-snip-inherited=58><span data-snip-inherited=58><span><span>与你分享肿瘤生物医药领域最新行业研究进展</span></span></span></section><section data-snip-inherited=58><span data-snip-inherited=58><span><span>和我的所思所学所想</span></span></span></section><section data-snip-inherited=58><span data-snip-inherited=58><span><span>点击 </span><span><strong>阅读原文 </strong></span></span><span>or</span><span><span> <strong>扫码</strong></span><span> 订阅熊言熊语邮件通讯</span></span></span></section><p data-snip-inherited=58><img data-galleryid data-ratio=0.25997425997426 data-s=300,640 data-src="https://mmbiz.qpic.cn/mmbiz_png/vMCuh4qxbFkmnldrkyncUOs2opE9rtrlTlgib1NXsOeOUFEH5gY65mDFASTA1q957DxqlseAm2qLic9X8iaYPVRJg/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1" data-type=png data-w=3885 src="https://mmbiz.qpic.cn/mmbiz_png/vMCuh4qxbFkmnldrkyncUOs2opE9rtrlTlgib1NXsOeOUFEH5gY65mDFASTA1q957DxqlseAm2qLic9X8iaYPVRJg/640?wx_fmt=png&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1"></p><section><span><br></span></section><section><section><br></section></section><p><mp-style-type data-value=3></mp-style-type></p></div><hr><a href=https://mp.weixin.qq.com/s/RS7RMRszEfRJd9dxR1ixyA ,target=_blank rel="noopener noreferrer">原文链接</a></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/fetched/ rel=tag>fetched</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/%E7%86%8A%E8%A8%80%E7%86%8A%E8%AF%AD/ rel=tag>熊言熊语</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/others/%E7%86%8A%E8%AF%B4%E8%82%BF%E7%98%A4_%E9%82%A3%E4%BA%9B%E8%8E%B7%E5%BE%97_fda_%E7%AA%81%E7%A0%B4%E6%80%A7%E8%AE%BE%E5%A4%87%E8%AE%A4%E8%AF%81%E7%9A%84%E5%A4%9A%E7%99%8C%E7%A7%8D%E6%97%A9%E7%AD%9B%E5%89%8D%E8%BE%88/ rel=prev><span class=pager__subtitle>«&#8201;Previous</span><p class=pager__title>熊说肿瘤｜那些获得 FDA 突破性设备认证的多癌种早筛前辈</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/others/%E8%A7%82%E7%82%B9_%E4%B8%8E%E5%85%B6%E5%90%90%E6%A7%BD%E5%A4%A7%E5%AD%A6%E6%95%99%E6%9D%90_%E4%B8%8D%E5%A6%82%E6%8E%8C%E6%8F%A1%E6%96%B9%E6%B3%95%E8%AE%A9%E8%87%AA%E5%B7%B1%E7%AA%81%E5%9B%B4/ rel=next><span class=pager__subtitle>Next&#8201;»</span><p class=pager__title>观点：与其吐槽大学教材，不如掌握方法让自己突围</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Search… name=q aria-label=Search…>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/2025-09/%E9%97%B2%E9%B1%BC%E4%B8%8A%E9%82%A3%E4%BA%9B%E9%80%86%E5%A4%A9%E7%9A%84%E6%B5%8B%E5%BA%8F%E4%BB%AA/>闲鱼上那些逆天的测序仪</a></li><li class=widget__item><a class=widget__link href=../../../posts/2025-09/%E8%AF%B4%E8%B5%B7%E8%BE%9B%E8%8A%B7%E8%95%BE_%E6%88%91%E6%83%B3%E8%B5%B7%E6%97%A9%E5%B9%B4%E4%B8%80%E4%BA%9B%E5%93%81%E5%91%B3_%E7%8B%AC%E7%89%B9_%E7%9A%84%E6%81%90%E6%80%96%E7%89%87/>说起辛芷蕾，我想起早年一些品味“独特”的恐怖片</a></li><li class=widget__item><a class=widget__link href=../../../posts/2025-09/%E5%A4%9A%E6%AC%A1%E7%94%9F%E5%AD%90%E5%90%8E_28%E5%B2%81%E5%86%9C%E6%9D%91%E6%99%BA%E9%9A%9C%E5%A5%B3%E5%AD%A9%E6%82%84%E7%84%B6%E7%A6%BB%E4%B8%96/>多次生子后，28岁农村智障女孩悄然离世</a></li><li class=widget__item><a class=widget__link href=../../../posts/2025-09/openai%E7%BD%95%E8%A7%81%E5%8F%91%E8%AE%BA%E6%96%87_%E6%88%91%E4%BB%AC%E6%89%BE%E5%88%B0%E4%BA%86ai%E5%B9%BB%E8%A7%89%E7%9A%84%E7%BD%AA%E9%AD%81%E7%A5%B8%E9%A6%96/>OpenAI罕见发论文：我们找到了AI幻觉的罪魁祸首</a></li><li class=widget__item><a class=widget__link href=../../../posts/2025-09/%E5%8D%97%E4%BA%AC%E5%8D%96%E6%B7%AB%E5%A4%B4%E7%9B%AE1_34%E4%BA%BF%E6%B8%AF%E5%85%83%E8%A2%AB%E7%91%9E%E9%93%B6%E5%8E%9F%E5%89%AF%E6%80%BB%E7%9B%91%E7%A7%81%E5%90%9E/>南京卖淫头目1.34亿港元被瑞银原副总监私吞</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/duty/>Duty</a></li><li class=widget__item><a class=widget__link href=../../../categories/duty2/>Duty2</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/cnbeta/ title=Cnbeta>Cnbeta (148)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/datawhale/ title=Datawhale>Datawhale (9)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/drpei/ title=Drpei>Drpei (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/fetched/ title=Fetched>Fetched (755)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/githubdaily/ title=GitHubDaily>GitHubDaily (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E4%B8%81%E9%A6%99%E5%9B%AD/ title=丁香园>丁香园 (30)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E4%BA%BA%E7%89%A9/ title=人物>人物 (15)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E5%8D%97%E6%96%B9%E5%91%A8%E6%9C%AB/ title=南方周末>南方周末 (11)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E5%B0%8F%E4%BC%97%E8%BD%AF%E4%BB%B6/ title=小众软件>小众软件 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E5%B0%8F%E5%A4%A7%E5%A4%AB%E6%BC%AB%E7%94%BB/ title=小大夫漫画>小大夫漫画 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E5%B0%91%E6%95%B0%E6%B4%BE/ title=少数派>少数派 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E5%BE%AA%E5%9B%A0%E7%BC%89%E8%8D%AF/ title=循因缉药>循因缉药 (9)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%96%B0%E4%B9%A1%E5%9C%9F/ title=新乡土>新乡土 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%98%9F%E7%90%83%E5%95%86%E4%B8%9A%E8%AF%84%E8%AE%BA/ title=星球商业评论>星球商业评论 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%9C%88%E5%85%89%E5%8D%9A%E5%AE%A2/ title=月光博客>月光博客 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%9C%AA%E9%97%BBcode/ title=未闻Code>未闻Code (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%A7%BD%E8%BE%B9%E5%BE%80%E4%BA%8B/ title=槽边往事>槽边往事 (9)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%AF%8F%E6%97%A5%E4%BA%BA%E7%89%A9/ title=每日人物>每日人物 (10)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%B5%AA%E6%BD%AE%E5%B7%A5%E4%BD%9C%E5%AE%A4/ title=浪潮工作室>浪潮工作室 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E6%B5%AE%E4%B9%8B%E9%9D%99/ title=浮之静>浮之静 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E7%81%BC%E8%A7%81/ title=灼见>灼见 (8)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E7%86%8A%E8%A8%80%E7%86%8A%E8%AF%AD/ title=熊言熊语>熊言熊语 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E7%94%9F%E4%BF%A1%E6%8A%80%E8%83%BD%E6%A0%91/ title=生信技能树>生信技能树 (10)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E7%94%9F%E4%BF%A1%E8%8F%9C%E9%B8%9F%E5%9B%A2/ title=生信菜鸟团>生信菜鸟团 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E7%9F%A5%E8%AF%86%E5%88%86%E5%AD%90/ title=知识分子>知识分子 (14)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E7%BD%91%E6%98%93%E6%95%B0%E8%AF%BB/ title=网易数读>网易数读 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E8%B4%A2%E6%96%B0/ title=财新>财新 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E8%B4%A2%E7%BB%8F%E4%B8%89%E5%88%86%E9%92%9F/ title=财经三分钟>财经三分钟 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E8%B5%9B%E5%85%88%E7%94%9F/ title=赛先生>赛先生 (5)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/%E9%83%91%E5%B7%9E%E6%A5%BC%E5%B8%82/ title=郑州楼市>郑州楼市 (32)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2025 文字轨迹.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>